Having trouble accessing articles? Reset your cache.

U.S. restrictions, EU suspension for Avandia

FDA and the European Medicines Agency issued simultaneous decisions on Thursday based on cardiovascular safety concerns that would significantly restrict use of Avandia rosiglitazone in the U.S. and

Read the full 283 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE